Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

ASH 2024 Summary: Full or Reduced Dose Apixaban or Rivaroxaban for E…

2024 ASH Annual Meeting Insights Hub

J. Schaefer

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

Thrombophilia Screening: Best Practices and Who Should Be Tested

COR2ED The Heart of Medical Education

S. Middeldorp, J. Connors

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Key Insights on the FDA Approval of Marstacimab for Hemophilia

Akshat Jain

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Classical Hematology: Managing Disorders of Bleeding and Clotting

Indy Hematology Review

C. Kessler

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

Marc Zumberg

PNH: Summary of Latest Advancements and Case Discussion

SOHO Brazil 2024

B. Fattizzo

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Medical Specialty Institute

P. Grayson

Type 1 Plasminogen Deficiency: Disease Overview and Evolving Managem…

Amy Shapiro

Updates on the Evolving Treatment Landscape for ITP

Cindy Neunert